Nauka i natura

Creative Biolabs

anti EGFRvA car t from Creative Biolabs that has expanded to the entire new drug discovery and development pipeline, including early discovery, preclinical testing, process development, cGMP manufacturing, phase 277-III clinical trials. https://www.creative-biolabs.com/car-t/target-egfrva-41.htm
Momencik, trwa przetwarzanie danych   loading-animation